Medicare Marketing Modifications: The Old and the New

This February, Centers for Medicare and Medicaid Services (CMS) announced an update to the Medicare Communications and...

Read More

The Third Step in Specialty Drug Management: Predicting the Impact

In our four-part series on specialty drug management, we have covered the importance of monitoring drugs before FDA...

Read More

Developments in Diabetes Medications: The Many Benefits of GLP-1 Agonists

Diabetes is a growing concern in the United States, with 35 million individuals impacted by type 2 diabetes mellitus...

Read More

Demonstrating the Value of Specialty Medications that Treat Multiple Sclerosis

There is no cure for the debilitating disease multiple sclerosis (MS); however, there are treatments that can slow...

Read More

The Process of Getting Members Safe and Convenient Access to Medications

Like everything in the healthcare industry, the pharmacy space is continually changing, from regulations to pharmacy...

Read More

The Second Step in Specialty Drug Management: Utilization Management

Continuing our four-part series on specialty drug management, we first discussed the importance of monitoring drugs...

Read More

Is it 2023 Already? Planning for Contract Year 2023 has Begun for Health Plans

Now that everyone has taken a moment to breathe and maybe a couple of days off after a successful launch of the...

Read More

Demonstrating the Value of Specialty Inflammatory Medications

Inflammatory medications are one of the top drivers of specialty drug spend. While these costly drugs can provide...

Read More

The First Step in Specialty Drug Management: Pipeline Monitoring and Review

The pipeline of new drugs coming to market continues to be steady, with 50 novel drugs approved by the FDA in 2021.[1] ...

Read More

Five Pipeline Developments to Watch in 2022

From continuing revolutionary advancements in gene therapy to the ongoing effects of the COVID-19 pandemic and the...

Read More